Company dossier

Aurobindo Pharma

NSE:AUROPHARMA · ISIN INE406A01037

Close: Unavailable
Daily change: N/A
Evidence state: Building

Dossier

Aurobindo PharmaNSE:AUROPHARMA

Coverage

Canonical documents: 11
Annual reports: 8
Financial results: 0
Presentations: 0
Call documents: 0
Coverage checks: 0/0
Open gaps: 0

Ticker research deskAUROPHARMA dossier context attached

Missing something in AUROPHARMA?

System checks can pass and your research need can still be missing. Tell us what you expected to find in business.

Aurobindo Pharma

Business

Business evidence pack

Primary material for understanding Aurobindo Pharma

Source documents

Business-model synthesis will be generated from the company's annual reports, investor presentations and conference-call material. Until that layer is reconciled, IndiaTicker shows the source pack instead of company-specific claims.

19 Aug 25

General Updates - Aurobindo Pharma LimitedNSE · annual report · 2 pages

VerifiedArchived copy

14 Aug 25

Annual Report 2025 - Aurobindo Pharma Ltd.BSE · annual report · 253 pages

VerifiedArchived copy

11 Jul 22

Newspaper Advertisements - Aurobindo Pharma LimitedNSE · annual report · 3 pages

VerifiedArchived copy

09 Jul 22

Annual General Meeting - Aurobindo Pharma LimitedNSE · annual report · 323 pages

VerifiedArchived copy

07 Jul 22

General updates - Aurobindo Pharma LimitedNSE · annual report · 1 pages

VerifiedArchived copy

24 Aug 21

Updates - Aurobindo Pharma LimitedNSE · annual report · 301 pages

VerifiedArchived copy

03 Aug 21

Updates - Aurobindo Pharma LimitedNSE · annual report · 1 pages

VerifiedArchived copy

03 Aug 20

Updates - Aurobindo Pharma LimitedNSE · annual report · 1 pages

VerifiedArchived copy

Keep your research close.

Aurobindo Pharma

What should we find for AUROPHARMA?

Business

Primary material for understanding Aurobindo Pharma